Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention

This publication has 38 references indexed in Scilit:

• Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
  Atherosclerosis, 2005
• Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors
  Circulation, 2005
• Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke
  Circulation, 2005
• Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
  European Heart Journal, 2004
• Lipoprotein-Associated Phospholipase A ₂ Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population
  Circulation, 2004
• Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes
  Journal of Clinical Endocrinology & Metabolism, 2004
• Lipoprotein-Associated Phospholipase A ₂ , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
  Circulation, 2004
• Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
  Journal of Lipid Research, 2003
• A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women
  Journal of the American College of Cardiology, 2001
• Lipoprotein-Associated Phospholipase A₂as an Independent Predictor of Coronary Heart Disease
  New England Journal of Medicine, 2000